Connect your AI

OS Therapies OSTX Stock Issued During Period Value Conversion Of Warrants To Common Stock

Stock Issued During Period Value Conversion Of Warrants To Common Stock at other companies

Microbot MedicalMBOT

$163K—

Quantum Computing Inc.QUBT

$12K—

TidewaterTDW

$1K-100.0%

CorMedixCRMD

$750—

DJT

Trump Media & Technology GroupDJT

$94.1K-57.5%

Agrify CorporationRYM

$338.75K—

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:StockIssuedDuringPeriodValueConversionOfWarrantsToCommonStock.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's stock issued during period value conversion of warrants to common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's stock issued during period value conversion of warrants to common stock?: OS Therapies (OSTX) reported stock issued during period value conversion of warrants to common stock of $2.35M in Q1 2026.
What does stock issued during period value conversion of warrants to common stock mean?: The value of common stock issued upon the exercise of outstanding warrants by holders. This indicates the conversion of derivative liabilities or equity-linked instruments into permanent common equity.